Literature DB >> 19204941

Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.

Chen Li1, Min Yan, Jun Chen, Min Xiang, Zheng Gang Zhu, Yan Zheng Lin.   

Abstract

BACKGROUND AND OBJECTIVES: The prognosis for patients with stage IV gastric cancer is still very poor. The purpose of this study was to evaluate the surgical outcome and prognosis, and to determine the prognostic influence of sub-stages of stage IV gastric cancer.
METHODS: From 1992 to 2002, 287 patients histologically diagnosed with stage IV gastric cancer underwent gastrectomy at the Department of Surgery, Ruijin Hospital, China. Regarding TNM categories, we separated them into T1-3N3M0, T4N1-2M0, T4N3M0, and TanyNanyM1 groups. We compared the clinicopathological characteristics as well as the survival in these groups.
RESULTS: There were largest proportions of patients who underwent extended lymphadenectomy and curative gastrectomy in T1-3N3M0 group followed by T4N1-2M0, T4N3M0, and TanyNanyM1 groups. The survival rate of patients with sub-stage IVa (T1-3N3M0 and T4N1-2M0) tumors was significant higher than that of patients with sub-stage IVb (T4N3M0 and TanyNanyM1) tumors (P = 0.008). Multivariate analysis showed that sub-stage with the highest risk ratio (1.454), and the surgical curability were independent prognostic factors in patients with stage IV gastric cancer.
CONCLUSIONS: Sub-stages IVa (T1-3N3M0 and T4N1-2M0) and IVb (T4N3M0 and TanyNanyM1) may predict patients' prognosis more accurately. Curative resection should be performed whenever possible in patients with stage IV gastric cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19204941     DOI: 10.1002/jso.21242

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Hao Ran Yin; Yan Zheng Lin
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

2.  Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer.

Authors:  Wen-Hao Suo; Ning Zhang; Ping-Ping Wu; Lei Zhao; Ling-Jun Song; Wei-Wei Shen; Lin Zheng; Jing Tao; Xi-Dai Long; Guo-Hui Fu
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy.

Authors:  Ki Hwan Kim; Keun-Wook Lee; Sun Kyung Baek; Hye Jung Chang; Yu Jung Kim; Do Joong Park; Jee Hyun Kim; Hyung-Ho Kim; Jong Seok Lee
Journal:  Gastric Cancer       Date:  2011-03-04       Impact factor: 7.370

4.  Subclassification of stage IV gastric cancer (IVa, IVb, and IVc) and prognostic significance of substages.

Authors:  Yan Ma; Yingwei Xue; Yanfeng Li; Xiuwen Lan; Yongle Zhang; Ming Zhang
Journal:  J Gastrointest Surg       Date:  2009-12-01       Impact factor: 3.452

5.  Prognosis of pN3 stage gastric cancer.

Authors:  Jung Ryun Ahn; Minkyu Jung; Chan Kim; Min Hee Hong; Hong Jae Chon; Hye Ryun Kim; Hei-Cheul Jeung; Woo Jin Hyung; Sung Sook Lee; Hyun Cheol Chung; Sung Hoon Noh; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2009-06-30       Impact factor: 4.679

6.  Discussion of modifying stage IV gastric cancer based on Borrmann classification.

Authors:  Bin Yang; Guoqiang Wu; Xiaochen Wang; Xuefeng Zhang
Journal:  Tumour Biol       Date:  2013-02-13

7.  Evaluation of the 7th UICC TNM Staging System of Gastric Cancer.

Authors:  Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

8.  Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer.

Authors:  Luigina Graziosi; Elisabetta Marino; Emanuel Cavazzoni; Annibale Donini
Journal:  World J Surg Oncol       Date:  2013-05-20       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.